Strategy, advocacy and partnering for the orphan drug industry
”Interesting topics. Well organised. Excellent partnering opportunities.”
Sixera Pharma
The future of rare diseases and orphan drugs
- Discuss pressing issues such as the pricing and reimbursement debate, commercialisation challenges and engaging with patients during research and development of new therapies.
- Meet and interact with representatives from pharma, biotechs, payers, government, regulators, academia and patient groups.
- Use extended networking time to seek out and build partnerships to speed up the development of orphan drugs.
- Network with attendees of our co-located World Gene Therapy Congress.
Should you sponsor?
Why get involved?
Find out more about how you can promote your products at the orphan drug sector’s premier event by downloading the sponsorship brochure today.
"WODC is the key annual congress for anybody working in the rare disease arena.”
Oxford PharmaGenesis
Why sponsor?
- Speak to a room full of orphan drug experts
- Host a roundtable and meet your customers
- Let us organise 1-2-1 meetings for you
- Let us generate sales leads pre-event
- Take a private meeting room
Why exhibit?
- Show off your latest products & innovations
- Promote new services
- Educate your target market
- Generate new sales leads
- Raise brand profile
2015 sponsor & exhibitors
Gold Sponsor
Gold Sponsor
Gold Sponsor
Silver Sponsor
Silver Sponsor
Associate Sponsor
Associate Sponsor
Associate Sponsor
Associate Sponsor
Exhibitor
Exhibitor
Exhibitor
Exhibitor
Co-located with
Interactive Sessions Offer High Level Networking
“WODC is the key annual congress for anybody working in the rare disease arena.”
Oxford Pharmagenesis
“Well organised, good programme and most useful, the networking sessions.”
AlepSyr Biotech Consultancy
“The event was excellent for networking and gathering information.”
Ataxia South Wales
Be part of the conversation
Supporting Rare Disease Awareness
This blogpost is provided by Premier Research. By now, we’ve all seen the stats – 7,000 rare diseases. 50% of rare disease patients are children. ...
The post Supporting Rare Disease Awareness appeared first on Orphan Drugs.
Rare Disease Day Interview: Ana Mingorance-Le Meur, Dravet Syndrome Foundation
Ana Mingorance-Le Meur, Scientific Director at Dravet Syndrome Foundation spoke with us about her thoughts on how the sector is going to progress over next ...
The post Rare Disease Day Interview: Ana Mingorance-Le Meur, Dravet Syndrome Foundation appeared first on Orphan Drugs.
In honor of Rare Disease Day, World Orphan Drug Congress USA is giving back
We are constantly inspired by the work of the rare disease advocacy groups. Their tireless work to fight for Rare Disease recognition has laid the ...
The post In honor of Rare Disease Day, World Orphan Drug Congress USA is giving back appeared first on Orphan Drugs.
Join the Community
Strategy and innovation for the orphan drug and rare disease industry
Sign Up to Our Newsletter
